Your browser doesn't support javascript.
loading
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems.
Moreno-Alcántar, Guillermo; Picchetti, Pierre; Casini, Angela.
Affiliation
  • Moreno-Alcántar G; Chair of Medicinal and Bioinorganic Chemistry, School of Natural Sciences, Department of Chemistry, Technical University of Munich (TUM), Lichtenbergstr. 4, 85748, Garching b. München, Germany.
  • Picchetti P; Karlsruhe Institute of Technology (KIT), Institute of Nanotechnology, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
  • Casini A; Chair of Medicinal and Bioinorganic Chemistry, School of Natural Sciences, Department of Chemistry, Technical University of Munich (TUM), Lichtenbergstr. 4, 85748, Garching b. München, Germany.
Angew Chem Int Ed Engl ; 62(22): e202218000, 2023 05 22.
Article in En | MEDLINE | ID: mdl-36847211
ABSTRACT
The discovery of the medicinal properties of gold complexes has fuelled the design and synthesis of new anticancer metallodrugs, which have received special attention due to their unique modes of action. Current research in the development of gold compounds with therapeutic properties is predominantly focused on the molecular design of drug leads with superior pharmacological activities, e.g., by introducing targeting features. Moreover, intensive research aims at improving the physicochemical properties of gold compounds, such as chemical stability and solubility in the physiological environment. In this regard, the encapsulation of gold compounds in nanocarriers or their chemical grafting onto targeted delivery vectors could lead to new nanomedicines that eventually reach clinical applications. Herein, we provide an overview of the state-of-the-art progress of gold anticancer compounds, andmore importantly we thoroughly revise the development of nanoparticle-based delivery systems for gold chemotherapeutics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Angew Chem Int Ed Engl Year: 2023 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Angew Chem Int Ed Engl Year: 2023 Document type: Article Affiliation country: Germany